Assembly Biosciences Inc (ASMB) Actualités

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates

Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366

– ABI-5366 was well-tolerated, with a favorable safety profile observed with exposure of up to 70 days – –...

Form S-8 - Securities to be offered to employees in employee benefit plans